DrugInformer Search

Clindamycin Phosphate In Dextrose 5%

Ingredients: Clindamycin Phosphate
Average User Review Score
* Based on 3 reviews from across the web.

No description available.


  Please use Workbench for in-depth research on Clindamycin Phosphate In Dextrose 5%.

Common adverse events from online conversations
Common adverse events from FDA database
* Extracted from FDA Adverse Event Reports for all drugs with the same active ingredients.

Tell us about your Experience with Clindamycin Phosphate In Dextrose 5%

Thank you for sharing your experience with us!

Share Your Experience

Druginformer Identified Side Effects: Adverse event

Posted By Anonymous in askapatient.com on March 31, 2014 @ 12:00 am

Side Effects: Soft stools. No other side effects This antibiotic probably saved my life. I had been ill for years without any doctor being able to tell me what is wrong with me. Possible ab...

Druginformer Identified Side Effects: None

Posted By Anonymous in askapatient.com on November 27, 2007 @ 12:00 am

Side Effects: I went to the doctor for a sinus infection and she noticed I was broke out real bad. She mentioned this and wrote me a prescription my skin improved ASAP! I have had acne since I was ...

Druginformer Identified Side Effects: Burning sensation, Hot flush

Posted By Anonymous in askapatient.com on June 22, 2007 @ 12:00 am

Side Effects: No side effects except for slight burning/hot feeling when I first started using the product. I use 2x/day. Saw improvement immediately. I love this product; my skin is perfe...

* Warning: The facts and figures contained in these reports are accurate to the best of our capability; however, our metrics are only meant to augment your medical knowledge, and should never be used as the sole basis for selecting a new medication. As with any medical decision, be sure to work with your doctor to ensure the best choices are made for your condition.

* About FAERS: The FDA Adverse Event Reporting System (FAERS) is used by FDA for activities such as looking for new safety concerns that might be related to a marketed product, evaluating a manufacturer's compliance to reporting regulations and responding to outside requests for information. Reporting of adverse events is a voluntary process, and not every report is sent to FDA and entered into FAERS. The FAERS database may contain duplicate reports, the report quality is variable, and many factors may influence reporting (e.g., media attention, length of time a drug is marketed, market share). For these reasons, FAERS case reports cannot be used to calculate incidence or estimates of risk for a particular product or compare risks between products.